APECED syndrome
|
(APS)
Acronym for Autoimmune PolyEndocrinopathy Candidasis Ectodermal Dystrophy
APECED type 1 : [MIM 240 300]
(polyglandular syndrome type 1)
Prevalence < 1.106 but the prevalence is higher in some groups in Finland, Sardinia and in the Jewish population in Iran. Autosomal recessive transmission of a mutation of the AIRE gene (21q22.3) which codes for a regulating protein of autoimmunity in the thymus. A deficiency in this protein results in the presence, in the blood, of T regulator lymphocytes (Treg) capable of interacting with specific antigens of the patient.
Clinical signs are highly variable:
▪ autoimmune involvement:
- hypoparathyroidism, before the age of 10 years, 80 % of all cases
- adrenal insufficiency, 78 % of cases
- autoimmune hepatitis
- celiac disease
- atrophic gastritis with Biermer's anemia
▪ ectodermal involvement:
- areas of skin depigmentation (vitiligo)
- dystrophy of the nails
- anomalies of dental enamel
- areas of alopecia
- involvement of the cornea
▪ mucocutaneous candidosis: recurring thrush in the early months of life, infection of the mucosae and the nails.
Increased risk of oropharyngeal and gastric cancers ?
Treatment: symptomatic for the hormonal deficiencies, fluconazole for the candidosis .
APECED type 2 or Schmidt syndrome [269 200 MIM]
Estimated prevalence of about 14-20 cases /106 with a significant female preponderance (4/1). Autoimmune disease of unknown origin that usually starts between 30 and 40 years of age. Endocrine glands are mainly involved. The clinical manifestations are highly variable:
- adrenal failure
- hypothyroiditis followed by hypothyroidism or hyperthyroidism
Sometimes: diabetes mellitus, hypoparathyroidism, hypogonadism, pernicious anemia by deficiency in vitamin B12, celiac disease, vitiligo.
Anesthetic implications:
substitutive opotherapy for the hormonal deficiencies
References :
- Puzenat E, Pepin L, Bertrand A-M, Pelletier F et al.
Polyendocrinopathie auto-immune de type 1 ou syndrome APECED.
Ann Dermatol Vénéréol 2010 ; 137 :794-8.
Updated: March 2018